Table 5.

Rates of response and toxicities among CAR-T recipients based on dynamic GA-MDC recommendation

OutcomeDynamic GA-MDC recommendationAll patients (N = 53)P value
Proceed (n = 47)Decline (n = 6)
Response rate, n (%) 21 (44.7) 5 (83.3) 26 (49.1) .10 
LOS, median (range) 17.0 (69.0) 30.5 (48.0) 17.0 (69.0) .05 
Discharge to rehabilitation center, n (%) 5 (10.6) 4 (66.7) 9 (17.0) .01 
Readmission, n (%) 15 (31.9) 2 (33.3) 28 (32.1) 1.00 
ICU admission, n (%) 3 (6.4) 3 (50.0) 6 (11.3) .76 
ICANS rate, n (%)  
Any grade 22 (46.8) 3 (50.0) 25 (47.2) 1.00 
0-1 33 (70.2) 3 (50.0) 36 (67.9) .37 
2+ 14 (29.8) 3 (50.0) 17 (32.1)  
CRS rate, n (%)  
Any grade 40 (85.1) 5 (83.3) 45 (84.9) 1.00 
0-1 32 (68.1) 4 (66.7) 36 (67.9) 1.00 
2+ 15 (31.91) 2 (33.3) 17 (32.1)  
OutcomeDynamic GA-MDC recommendationAll patients (N = 53)P value
Proceed (n = 47)Decline (n = 6)
Response rate, n (%) 21 (44.7) 5 (83.3) 26 (49.1) .10 
LOS, median (range) 17.0 (69.0) 30.5 (48.0) 17.0 (69.0) .05 
Discharge to rehabilitation center, n (%) 5 (10.6) 4 (66.7) 9 (17.0) .01 
Readmission, n (%) 15 (31.9) 2 (33.3) 28 (32.1) 1.00 
ICU admission, n (%) 3 (6.4) 3 (50.0) 6 (11.3) .76 
ICANS rate, n (%)  
Any grade 22 (46.8) 3 (50.0) 25 (47.2) 1.00 
0-1 33 (70.2) 3 (50.0) 36 (67.9) .37 
2+ 14 (29.8) 3 (50.0) 17 (32.1)  
CRS rate, n (%)  
Any grade 40 (85.1) 5 (83.3) 45 (84.9) 1.00 
0-1 32 (68.1) 4 (66.7) 36 (67.9) 1.00 
2+ 15 (31.91) 2 (33.3) 17 (32.1)  

Deferred or declined patients successfully completing optimization recommendations that constituted the initial barrier were reclassified as proceed for the dynamic GA-MDC recommendation. All others were classified as declined.

Close Modal

or Create an Account

Close Modal
Close Modal